Namyangju, South Korea

Mi Jung Kim

This inventor holds 1 USPTO granted patent. Top assignee: Hlb Pharmaceutical Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Jung Kim. Retrieved from https://idiyas.com/inventor/mi-jung-kim-l4jwuvva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi Jung Kim - Innovator in Biodegradable Microsphere Technology.

Introduction

Mi Jung Kim is a notable inventor based in Namyangju-Si, South Korea. He has made significant contributions to the field of biodegradable materials, particularly through his innovative methods for preparing biodegradable microspheres.

Latest Patents

Mi Jung Kim holds a patent for a "Method for preparing biodegradable microspheres using stabilized single-phase mixed solution." This invention relates to a method that utilizes a single-phase mixed solution containing water, alcohol, and dichloromethane. The method ensures uniform drug loading efficiency without the need for thickeners or surfactants. This innovative approach maintains the content of the loaded drug uniform throughout the preparation process, making it remarkably useful for creating biodegradable microspheres.

Career Highlights

Mi Jung Kim is currently associated with HLB Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on enhancing the efficiency and effectiveness of biodegradable materials in pharmaceutical applications.

Collaborations

Some of his coworkers include Sang Hwi Lee and Mijung Kim, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Mi Jung Kim's innovative work in biodegradable microsphere technology showcases his commitment to advancing sustainable solutions in pharmaceuticals. His contributions are paving the way for more effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…